Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
Abstract Background Central nervous system (CNS) metastasis is common in advanced melanoma patients. New treatment options have improved overall prognosis, but information is lacking for patients with CNS metastases. We investigated treatment patterns and survival outcomes in older melanoma patients...
Main Authors: | Natalia Sadetsky, Alexandra Hernandez, Chris J. Wallick, Edward F. McKenna, Andy Surinach, Dawn E. Colburn |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3256 |
Similar Items
-
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
by: Serigne N. Lo, et al.
Published: (2019-08-01) -
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
by: Hauswald Henrik, et al.
Published: (2012-08-01) -
Efficacy of lorlatinib treatment in ALK rearrangement lung cancer with severe symptomatic central nervous system metastases and poor performance status
by: Tomoyo Taketa, et al.
Published: (2021-04-01) -
Malignant melanoma with liver and spleen metastases: case report
by: Laura Cotta Ornellas, et al.
Published: (2000-03-01) -
Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
by: Paul Lesueur, et al.
Published: (2018-07-01)